Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: A HuGE-GSEC review

American Journal of Epidemiology

Volumn 169, Issue 7, 2009, Pages 802-814

  Cote, Michele L ^a   Chen, Wei ^a   Smith, Daryn W ^b   Benhamou, Simone ^c,d   Bouchardy, Christine ^e   Butkiewicz, Dorota ^f   Fong, Kwun M ^g   Gené, Manuel ^h   Hirvonen, Ari ⁱ   Kiyohara, Chikako ^j   Larsen, Jill E ^k   Lin, Pinpin ^l   Raaschou Nielsen, Ole ^m   Povey, Andrew C ⁿ   Reszka, Edyta ^o   Risch, Angela ^p   Schneider, Joachim ^q   Schwartz, Ann G ^a   Sorensen, Mette ^m   To Figueras, Jordi ^r   Tokudome, Shinkan ^s   Pu, Yuepu ^t   Yang, Ping ^u   Wenzlaff, Angela S ^a   Wikman, Harriet ^v   Taioli, Emanuela ^w   more..

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c INSERM   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e GENEVA CANCER REGISTRY   (Switzerland)

^f INSTITUTE OF ONCOLOGY   (Poland)

^g THE PRINCE CHARLES HOSPITAL   (Australia)

^h UNIVERSITY OF BARCELONA   (Spain)

ⁱ FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^j KYUSHU UNIVERSITY   (Japan)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^m INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

ⁿ UNIVERSITY OF MANCHESTER   (United Kingdom)

^o NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q JUSTUS LIEBIG UNIVERSITY   (Germany)

^r HOSPITAL CLÍNIC   (Spain)

^s NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^t SOUTHEAST UNIVERSITY   (China)

^u Mayo Clinic   (United States)

^v UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^w UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

more..

Author keywords

Asian continental ancestry group; Epidemiology; Glutathione S transferase pi; GSTP1; Lung neoplasms; Smoking

Indexed keywords

ALLELE; CANCER; CARCINOGEN; DETOXIFICATION; ENZYME ACTIVITY; EPIDEMIOLOGY; GENE EXPRESSION; HISTOLOGY; META-ANALYSIS; METABOLISM; PAH; POLYMORPHISM; RESPIRATORY DISEASE; RISK FACTOR; SMOKING;

ASIAN; CANCER RISK; EUROPEAN AMERICAN; EXON; GENE; GENETIC POLYMORPHISM; GENOTYPE; GSTP1 GENE; HUMAN; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; REVIEW; SMOKING; ARTICLE; CAUCASIAN; ETHNOLOGY; GENETICS; LUNG TUMOR; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

GLUTATHIONE TRANSFERASE P1;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 63149187299     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn417     Document Type: Review

References (81)

1. Anttila S, Hirvonen A, Vainio H, et al. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res. 1993;53(23):5643-5648.
2. Ketterer B, Harris JM, Talaska G, et al. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect. 1992;98:87-94.
3. Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemother-apeutic drugs? Biofactors. 2003;17(1-4):115-130.
4. Goto S, Iida T, Cho S, et al. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res. 1999;31(6):549-558.
5. Nakagawa K, Saijo N, Tsuchida S, et al. Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. J Biol Chem. 1990;265(8):4296-4301.
6. Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett. 2000;112-113: 357-363.
7. Ali-Osman F, Brunner JM, Kutluk TM, et al. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin Cancer Res. 1997;3(12 pt 1):2253-2261.
8. Armstrong RN. Glutathione S-transferases: reaction mechanism, structure, and function. Chem Res Toxicol. 1991;4(2): 131-140.
9. Strange RC, Faulder CG, Davis BA, et al. The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet. 1984;48(pt 1):11-20.
10. Kiyohara C, Shirakawa T, Hopkin JM. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer. Environ Health Prev Med. 2002;7:47-59.
11. Ali-Osman F, Akande O, Antoun G, et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272(15):10004-10012.
12. Hu X, Ji X, Srivastava SK, et al. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys. 1997;345(1):32-38.
13. Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of poly-cyclic aromatic hydrocarbons. Carcinogenesis. 1998;19(3): 433-436.
14. Butkiewicz D, Grzybowska E, Phillips DH, et al. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA ad-ducts in human mononuclear white blood cells. Environ Mol Mutagen. 2000;35(2):99-105.
15. Ye Z, Song H, Higgins JP, et al. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies [electronic article]. PLo S Med. 2006;3(4):e91.
16. Shibuya K, Mathers CD, Boschi-Pinto C, et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000 [electronic article]. BMC Cancer. 2002;2:37.
17. Ries LA, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003.
18. Wu AH, Henderson BE, Thomas DC, et al. Secular trends in histologic types of lung cancer. J Natl Cancer Inst. 1986;77(1): 53-56.
19. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 suppl):21S-49S.
20. Ando M, Wakai K, Seki N, et al. Attributable and absolute risk of lung cancer death by smoking status: findings from the Japan Collaborative Cohort Study. Int J Cancer. 2003; 105(2): 249-254.
21. Chan-Yeung M, Koo LC, Ho JC, et al. Risk factors associated with lung cancer in Hong Kong. Lung Cancer. 2003;40(2): 131-140.
22. Shankar A, Yuan JM, Koh WP, et al. Morbidity and mortality in relation to smoking among women and men of Chinese ethnicity: the Singapore Chinese Health Study. Eur J Cancer. 2008;44(1):100-109.
23. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package. Geneva, Switzerland: World Health Organization; 2008.
24. Alavanja MC, Brownson RC, Benichou J, et al. Attributable risk of lung cancer in lifetime nonsmokers and long-term ex-smokers (Missouri, United States). Cancer Causes Control. 1995;6(3):209-216.
25. Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene 2004;23(38):6392-6403.
26. Krewski D, Lubin JH, Zielinski JM, et al. A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health. 2006;69(7):533-597.
27. Cowell IG, Dixon KH, Pemble SE, et al. The structure of the human glutathione S-transferase pi gene. Biochem J. 1988; 255(1):79-83.
28. Kiyohara C, Otsu A, Shirakawa T, et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer. 2002;37(3):241-256.
29. Mohr LC, Rodgers JK, Silvestri GA. Glutathione S-transferase M1 polymorphism and the risk of lung cancer. Anticancer Res. 2003;23(3A):2111-2124.
30. Skuladottir H, Autrup H, Autrup J, et al. Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung Cancer. 2005;48(2): 187-199.
31. Perera FP, Mooney LA, Stampfer M, et al. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis. 2002;23(10): 1641-1646.
32. Butkiewicz D, Cole KJ, Phillips DH, et al. GSTM1, GSTP1, CYP1 A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur J Cancer Prev. 1999; 8(4):315-323.
33. Sweeney C, Nazar-Stewart V, Stapleton PL, et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2003;12(6):527-533.
34. Yang P, Yokomizo A, Tazelaar HD, et al. Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes. Lung Cancer. 2002;35(3):221-229.
35. Lu C, Spitz MR, Zhao H, et al. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006; 106(2):441-447.
36. Miller DP, Neuberg D, de Vivo I, et al. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology. 2003;14(5):545-551.
37. Sørensen M, Autrup H, Tjonneland A, et al. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer. 2004;110(2):219-224.
38. Tsai YY, McGlynn KA, Hu Y, et al. Genetic susceptibility and dietary patterns in lung cancer. Lung Cancer. 2003;41(3): 269-281.
39. Cote ML, Kardia SL, Wenzlaff AS, et al. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis. 2005;26(4):811-819.
40. Wenzlaff AS, Cote ML, Bock CH, et al. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study. Carcinogenesis. 2005;26(2):395-401.
41. Kiyohara C, Yamamura KI, Nakanishi Y, et al. Polymorphism in GSTM1, GSTT1, and GSTP1 and susceptibility to lung cancer in a Japanese population. Asian Pac J Cancer Prev. 2000;1(4):293-298.
42. Liang G, Pu Y, Yin L. Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett. 2005;223(2):265-274.
43. Chan EC, Lam SY, Fu KH, et al. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet. 2005; 162(1): 10-20.
44. Chan-Yeung M, Tan-Un KC, Ip MS, et al. Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer. 2004;45(2): 155-160.
45. Harris MJ, Coggan M, Langton L, et al. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 1998;8(1):27-31.
46. Jourenkova-Mironova N, Wikman H, Bouchardy C, et al. Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics. 1998;8(6):495-502.
47. Katoh T, Kaneko S, Takasawa S, et al. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics. 1999;9(2):165-169.
48. Kihara M, Kihara M, Noda K. Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett. 1999; 137(1):53-60.
49. Larsen JE, Colosimo ML, Yang IA, et al. CYP1 A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis. 2006;27(3):525-532.
50. Lewis SJ, Cherry NM, Niven RM, et al. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 2002;180(2):165-171.
51. Lin P, Hsueh YM, Ko JL, et al. Analysis of NQO1, GSTP1, and Mn SOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer. 2003;40(2): 123-129.
52. Miller DP, Asomaning K, Liu G, et al. An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma. Cancer. 2006; 107(7): 1570-1577.
53. Nazar-Stewart V, Vaughan TL, Stapleton P, et al. A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer. 2003;40(3): 247-258.
54. Reszka E, Wasowicz W, Rydzynski K, et al. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition. Neoplasma. 2003;50(5):357-362.
55. Saarikoski ST, Voho A, Reinikainen M, et al. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer. 1998;77(4):516-521.
56. Schneider J, Bernges U, Philipp M, et al. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett. 2004;208(1):65-74.
57. Sorensen M, Raaschou-Nielsen o, Brasch-Andersen C, et al. Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer. 2007;55(2):137-144.
58. Stücker I, Hirvonen A, de Waziers I, et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis. 2002;23(9): 1475-1481.
59. To-Figueras J, Gené M, Gómez-Catalán J, et al. Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Control. 1999;10(1):65-70.
60. Wang J, Deng Y, Cheng J, et al. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett. 2003;201 (2): 185-193.
61. Wang Y, Spitz MR, Schabath MB, et al. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003; 40(1):25-32.
62. Yang P, Bamlet WR, Ebbert JO, et al. Glutathione pathway genes and lung cancer risk in young and old populations. Carcinogenesis. 2004;25(10): 1935-1944.
63. Risch A, Wikman H, Thiel S, et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharma-cogenetics. 2001;11(9):757-764.
64. Ryberg D, Skaug V, Hewer A, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997;18(7): 1285-1289.
65. Taioli E. International collaborative study on genetic susceptibility to environmental carcinogens. Cancer Epidemiol Biomarkers Prev. 1999;8(8):727-728.
66. Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care: Meta-analysis in Context. London, United Kingdom: BMJ Books; 2001.
67. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
68. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4): 1088-1101.
69. Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315 (7109): 629-634.
70. Kellen E, Hemelt M, Broberg K, et al. Pooled analysis and meta-analysis of the glutathione S-transferase P1I le 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol. 2007;165(11):1221-1230.
71. Ye Z, Song H. Glutathione S-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer. 2005;41(7):980-989.
72. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
73. Green JP, Brophy P. Carcinoma of the lung in nonsmoking Chinese women. West J Med. 1982;136(4):291-294.
74. Engelman JA, Jänne PA. Factors predicting response to EGFR tyrosine kinase inhibitors. Semin Respir Crit Care Med. 2005; 26(3):314-322.
75. Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5(1):14-20.
76. Ritchie KJ, Henderson CJ, Wang XJ, et al. Glutathione trans-ferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens andurethane. Cancer Res. 2007;67(19):9248-9257.
77. Inoue T, Ishida T, Sugio K, et al. Glutathione S transferase Pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma. Respiration. 1995;62(4):223-227.
78. Chiang TA, Wu PF, Ko YC. Identification of carcinogens in cooking oil fumes. Environ Res. 1999;81(1):18-22.
79. Gao YT, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer. 1987;40(5):604-609.
80. Pohlabeln H, Boffetta P, Ahrens W, et al. Occupational risks for lung cancer among nonsmokers. Epidemiology. 2000; 11(5):532-538.
81. Pan Z, Trikalinos TA, Kavvoura FK, et al. Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature [electronic article]. PLo S Med. 2005;2(12):e334.